Back to Library
Differential Responses of Chamber-Specific Human iPSC-Derived Cardiomyocytes for In Vitro Cardiotoxicity Studies
-
Posters
Loading PDF document…
Download Differential Responses of Chamber-Specific Human iPSC-Derived Cardiomyocytes for In Vitro Cardiotoxicity Studies PDF
Enter your details to unlock PDF access and receive your download link.
More information
The poster titled Differential Responses of Chamber-Specific Human iPSC-Derived Cardiomyocytes for In Vitro Cardiotoxicity Studies presents Axol Bioscience’s advanced platform for cardiac safety screening using human iPSC-derived cardiomyocytes with defined chamber identities.
Key highlights include:
- axoCells™ Atrial & Ventricular Cardiomyocytes: Derived from the same donor, validated by MLC2A/MLC2V expression and TempO-Seq transcriptomics. Atrial cells express KCNA5, NPPA, SLN; ventricular cells express HEY2, MYH7, MYL2.
- Left Ventricular Cardiomyocytes: A novel differentiation protocol yields ~90% purity with complete loss of atrial markers and ventricular-like action potentials.
- FLEXcyte™ 96 Contractility Assay: Measures beat rate, force amplitude, and beat-width. Atrial cells show faster beat rate and lower force; ventricular cells show stronger contraction.
- Drug Responses:
- Carbachol: Atrial-specific response due to I_KACh current.
- S-Bay K8644 (Ca²⁺ agonist): Opposing effects—atrial cells show reduced beat rate and increased force; ventricular cells show increased beat rate and reduced force.
- MyoMax™ Maturation Media: Promotes adult-like cardiomyocyte features including:
- Rod-shaped morphology and sarcomere alignment
- Shorter field potential duration (FPD)
- Faster conduction velocity
- Upregulated fatty acid metabolism genes (MDH1, ACAT1, FABP3)
- Electrophysiological Profiling: MEA analysis confirms improved maturity and functional performance in MyoMax-treated cells.
This platform enables chamber-specific cardiotoxicity screening with enhanced physiological relevance and supports drug development pipelines targeting cardiac safety.
Featured Axol Products:
- axoCells™ Atrial Cardiomyocytes – ax0510
- axoCells™ Ventricular Cardiomyocytes – ax0500
- axoCells™ Left Ventricular Cardiomyocytes – ax0505
- MyoMax™ Maturation Media – ax8001
- axoCells™ Cardiomyocyte Maintenance Media – ax8000